Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Aspart Filing Kicks Off Amphastar’s Insulin Ambitions
Could Amphastar Be In Line For The First US FDA Approval For A Novolog Biosimilar?
Mar 18 2024
•
By
Dave Wallace
Who will be first off the blocks with insulin aspart? • Source: Shutterstock
More from Biosimilars
More from Products